SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-036294
Filing Date
2024-03-19
Accepted
2024-03-19 20:00:26
Documents
2
Period of Report
2024-03-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm248792-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm248792-1_3seq1.xml 3 2517
2 EXHIBIT 24 tm248792d1_ex24.htm EX-24 8522
  Complete submission text file 0001104659-24-036294.txt   12522
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHECKPOINT THERAPEUTICS, INC. 95 SAWYER ROAD, SUITE 110 WALTHAM MA 02453
Business Address
Amit Sharma (Reporting) CIK: 0002016173 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38128 | Film No.: 24765857